Molecular and cellular mechanisms of inflammation in atherosclerosis

Nicoleta-Monica Popa-Fotea1,2, Corina-Elena Ferdoschi1, Miruna-Mihaela Micheu2

  • 1Department 4 Cardio-Thoracic Pathology, University of Medicine and Pharmacy "Carol Davila," Bucharest, Romania.

Insights

Inflammation drives atherosclerosis, a complex disease. This review details how immune cells and mediators like cytokines activate pathways that promote plaque development and complications.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pathology

Background:

  • Atherosclerosis is a leading global cause of death, despite advances in revascularization treatments.
  • Inflammation is a central, multi-step process in the initiation, progression, and complications of atherosclerotic plaques.

Purpose of the Study:

  • To review the cell axis activation in atherosclerosis.
  • To elucidate specific mechanisms and pathways through which inflammation drives atherosclerosis.

Main Methods:

  • Literature review of cellular and molecular mechanisms in atherosclerosis.
  • Analysis of immune system involvement and mediator functions.

Main Results:

  • Immune system activation enhances pro-atherogenic functions of various cells (endothelial, smooth muscle, platelets).
  • Cytokines mediate inflammation by stimulating immune cells and further cytokine production.
  • Cell-to-cell interactions also contribute directly to atherosclerotic dynamics.

Conclusions:

  • Inflammation is a critical driver of atherosclerosis, involving complex cell-axis interactions.
  • Understanding these inflammatory pathways is key to developing novel therapeutic strategies.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Inflammation01:38

Inflammation

Overview
53.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
11.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12